{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:55:53Z","timestamp":1792090553797,"version":"4.4.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymthe.2025.12.034","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T07:42:47Z","timestamp":1767080567000},"page":"1909-1920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Innovative approach in malaria research: Harnessing CRISPR-Cas9 for antimalarial drug-resistance studies in Africa"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-2366","authenticated-orcid":false,"given":"Olusola","family":"Ajibaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idowu Samuel","family":"Dada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haddijatou","family":"Mbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikechukwu Chidiebere","family":"Nwankwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eniyou","family":"Oriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Amambua-Ngwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.12.034_bib1","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1097\/MS9.0000000000002578","article-title":"Emerging public health strategies in malaria control: innovations and implications","volume":"86","author":"Obeagu","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.ymthe.2025.12.034_bib2","series-title":"World Malaria Report 2024: Addressing Inequity in the Global Malaria Response","year":"2024"},{"key":"10.1016\/j.ymthe.2025.12.034_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1295381","article-title":"Recent and historical advances in the life cycle, pathogenesis, diagnosis, prevention, and treatment of malaria, including perspectives from Ethiopia","volume":"2020","author":"Nureye","year":"2020","journal-title":"Sci. World J."},{"key":"10.1016\/j.ymthe.2025.12.034_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.pt.2023.09.011","article-title":"The many paths to artemisinin resistance in Plasmodium falciparum","volume":"39","author":"Pandit","year":"2023","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/acph-2023-0001","article-title":"Recent approaches in drug research and development of novel antimalarial drugs targeting new mechanisms","volume":"73","author":"Chinnappanna","year":"2023","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ymthe.2025.12.034_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.157","article-title":"Recent advances in the characterization of essential genes and the development of a database of important genes","volume":"3","author":"Liang","year":"2024","journal-title":"iMeta"},{"key":"10.1016\/j.ymthe.2025.12.034_bib7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/crispr.2024.0032","article-title":"Genome editing in apicomplexan parasites: Current status, challenges, and future possibilities","volume":"7","author":"Webi","year":"2024","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2025.12.034_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.61186\/ibj.27.5.219","article-title":"CRISPR-Cas technology as a revolutionary genome editing tool: mechanisms and biomedical applications","volume":"27","author":"Ebrahimi","year":"2023","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.ymthe.2025.12.034_bib9","article-title":"TALE and TALEN genome editing technologies","volume":"2","author":"Becker","year":"2021","journal-title":"Gene Genome Ed."},{"key":"10.1016\/j.ymthe.2025.12.034_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/genes14010129","article-title":"Recent advances in genome-engineering strategies","volume":"14","author":"Boti","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.ymthe.2025.12.034_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/microorganisms12010118","article-title":"Clustered regularly interspaced short palindromic repeat\/CRISPR-associated protein and its utility all at sea: status, challenges, and prospects","volume":"12","author":"Li","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ymthe.2025.12.034_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.915656","article-title":"Evaluation of the effect of gene duplication by genome editing on drug resistance in Plasmodium falciparum","volume":"12","author":"Kubota","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib13","series-title":"Malaria Immunology: Targeting the Surface of Infected Erythrocytes","first-page":"241","article-title":"CRISPR-Cas9 editing of the Plasmodium falciparum genome: special applications","author":"Zhang","year":"2022"},{"key":"10.1016\/j.ymthe.2025.12.034_bib14","doi-asserted-by":"crossref","first-page":"27777","DOI":"10.1073\/pnas.1915966117","article-title":"The importance of CRISPR-Cas systems in protecting natural bacterial populations against infections by mobile genetic elements remains unclear","volume":"117","author":"Westra","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.034_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-genet-071719-022559","article-title":"The tracrRNA in CRISPR biology and technologies","volume":"55","author":"Liao","year":"2021","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ymthe.2025.12.034_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124054","article-title":"CRISPR-Cas for genome editing: classification, mechanism, designing and applications","volume":"238","author":"Bhatia","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jobm.201900420","article-title":"CRISPR\/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing","volume":"60","author":"Khanzadi","year":"2020","journal-title":"J. Basic Microbiol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib18","series-title":"Biomedical Translational Research: Technologies for Improving Healthcare","first-page":"167","article-title":"CRISPR: Genome Editing and Beyond","author":"Aiana","year":"2022"},{"key":"10.1016\/j.ymthe.2025.12.034_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000516643","article-title":"CRISPR-Cas system: the powerful modulator of accessory genomes in prokaryotes","volume":"32","author":"Butiuc-Keul","year":"2022","journal-title":"Microb. Physiol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib20","doi-asserted-by":"crossref","first-page":"9604","DOI":"10.3390\/ijms21249604","article-title":"Various aspects of a gene editing system\u2014CRISPR\u2013Cas9","volume":"21","author":"Janik","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.12.034_bib21","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20221198","article-title":"CRISPR-Cas adaptation in Escherichia coli","volume":"43","author":"Miti\u0107","year":"2023","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ymthe.2025.12.034_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/bios14030145","article-title":"Detection of parasites in the field: the ever-innovating CRISPR\/Cas12a","volume":"14","author":"Li","year":"2024","journal-title":"Biosensors"},{"key":"10.1016\/j.ymthe.2025.12.034_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s43586-021-00093-4","article-title":"High-content CRISPR screening","volume":"2","author":"Bock","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.ymthe.2025.12.034_bib24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41576-025-00873-8","article-title":"Methods and applications of in vivo CRISPR screening","volume":"26","author":"Santinha","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2025.12.034_bib25","article-title":"CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability","author":"He","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ymthe.2025.12.034_bib26","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/s12276-025-01487-0","article-title":"Perturbomics: CRISPR\u2013Cas screening-based functional genomics approach for drug target discovery","volume":"57","author":"Park","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.034_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tig.2021.02.008","article-title":"DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing","volume":"37","author":"Xue","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymthe.2025.12.034_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102344","article-title":"CRISPR-Cas9-mediated homology-directed repair for precise gene editing","volume":"35","author":"Liao","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.12.034_bib29","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.cell.2021.01.005","article-title":"Genome engineering for crop improvement and future agriculture","volume":"184","author":"Gao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.12.034_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120409","article-title":"From DNA break repair pathways to CRISPR\/Cas-mediated gene knock-in methods","volume":"295","author":"Rezazade Bazaz","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2025.12.034_bib31","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.3390\/ijms23115992","article-title":"Improving homology-directed repair in genome editing experiments by influencing the cell cycle","volume":"23","author":"Smirnikhina","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.12.034_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1021\/acssynbio.4c00632","article-title":"CRISPR\/Cas-based gene editing tools for large DNA fragment integration","volume":"14","author":"Yang","year":"2025","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1134\/S0026893324700201","article-title":"How to shift the equilibrium of DNA break repair in favor of homologous recombination","volume":"58","author":"Averina","year":"2024","journal-title":"Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41392-024-01750-2","article-title":"Precise Genome Editing in Human Diseases: Mechanisms, Strategies, and Applications","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.12.034_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/crispr.2021.0039","article-title":"Strategies for enhancing the homology-directed repair efficiency of CRISPR-Cas systems","volume":"5","author":"Sun","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2025.12.034_bib36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/jof11040310","article-title":"Gene editing in Ganoderma lucidum: development, challenges, and future prospects","volume":"11","author":"He","year":"2025","journal-title":"J. Fungi"},{"key":"10.1016\/j.ymthe.2025.12.034_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2021.773052","article-title":"It is just a matter of time: balancing homologous recombination and non-homologous end joining at the rDNA locus during meiosis","volume":"12","author":"Sims","year":"2021","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.ymthe.2025.12.034_bib38","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/cancers13061392","article-title":"Alternative non-homologous end-joining: error-prone DNA repair as cancer\u2019s Achilles\u2019 heel","volume":"13","author":"Caracciolo","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ymthe.2025.12.034_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-biochem-080320-110356","article-title":"Repair of DNA double-strand breaks by the nonhomologous end joining pathway","volume":"90","author":"Stinson","year":"2021","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2025.12.034_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2024.103730","article-title":"DSB-induced oxidative stress: uncovering crosstalk between DNA damage response and cellular metabolism","volume":"141","author":"Li","year":"2024","journal-title":"DNA Repair"},{"key":"10.1016\/j.ymthe.2025.12.034_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnab080","article-title":"Gene targeting using pre-assembled Cas9 ribonucleoprotein and split-marker recombination in Pleurotus ostreatus","volume":"368","author":"Boontawon","year":"2021","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ymthe.2025.12.034_bib42","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/s12276-023-01057-2","article-title":"Genome editing in the treatment of ocular diseases","volume":"55","author":"Choi","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.034_bib43","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.3390\/ijms26094067","article-title":"Fine-tuning homology-directed repair (HDR) for precision genome editing: current strategies and future directions","volume":"26","author":"Haider","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.12.034_bib44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.molmed.2019.06.008","article-title":"CRISPR craze to transform cardiac biology","volume":"25","author":"van Kampen","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.034_bib45","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.18203\/2320-6012.ijrms20241589","article-title":"CRISPR\/Cas9-mediated genome editing: from basic research to gene therapy","volume":"12","author":"Goel","year":"2024","journal-title":"Int. J. Res. Med. Sci."},{"key":"10.1016\/j.ymthe.2025.12.034_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1292452","article-title":"Current trends of clinical trials involving CRISPR\/Cas systems","volume":"10","author":"Zhang","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.ymthe.2025.12.034_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1148412","article-title":"Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer","volume":"14","author":"Meng","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib48","series-title":"CRISPR Genome-Editing Studies Reveal Potential Vulnerabilities in Targeting Tumor-Suppressors and Oncogenes of Aggressive Cancers","author":"Boudreault","year":"2024"},{"key":"10.1016\/j.ymthe.2025.12.034_bib49","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1038\/s41467-020-18875-x","article-title":"In vivo CRISPR\/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells","volume":"11","author":"Martinez-Lage","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.034_bib50","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1097\/MS9.0000000000002146","article-title":"Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR\/Cas9 gene therapy for sickle cell disease","volume":"86","author":"Singh","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.ymthe.2025.12.034_bib51","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.3390\/cimb46080485","article-title":"Regulatory assessment of Casgevy for the treatment of transfusion-dependent \u03b2-thalassemia and sickle cell disease with recurrent vaso-occlusive crises","volume":"46","author":"Kerwash","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/bloodadvances.2024014040","article-title":"Nonclinical evaluation of HBG1\/2 and BCL11A as genome-editing targets for the treatment of \u03b2-hemoglobinopathies","volume":"9","author":"Janoudi","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.12.034_bib53","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s12035-022-03150-5","article-title":"CRISPR\/Cas9 mediated therapeutic approach in Huntington\u2019s disease","volume":"60","author":"Alkanli","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib54","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","article-title":"CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington\u2019s disease mouse model","volume":"17","author":"Ekman","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.12.034_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.12.034_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/jdb13010005","article-title":"CRISPR\/Cas9-targeted myostatin deletion improves the myogenic differentiation parameters for muscle-derived stem cells in mice","volume":"13","author":"Elashry","year":"2025","journal-title":"J. Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib57","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.12.034_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.869889","article-title":"The state-of-the-art of gene editing and its application to viral infections and diseases, including COVID-19","volume":"12","author":"Hawsawi","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2023.105419","article-title":"CRISPR\/Cas advancements for genome editing, diagnosis, therapeutics, and vaccine development for Plasmodium parasites, and genetic engineering of Anopheles mosquito vector","volume":"109","author":"Nourani","year":"2023","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274993","article-title":"Transcriptional changes in Plasmodium falciparum upon conditional knock down of mitochondrial ribosomal proteins RSM22 and L23","volume":"17","author":"Dass","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.12.034_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2302504","article-title":"Transforming malaria prevention and control: the prospects and challenges of gene drive technology for mosquito management","volume":"55","author":"Tajudeen","year":"2023","journal-title":"Ann. Med."},{"key":"10.1016\/j.ymthe.2025.12.034_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202100286","article-title":"Potential of the CRISPR-Cas system for improved parasite diagnosis: CRISPR-Cas mediated diagnosis in parasitic infections","volume":"44","author":"You","year":"2022","journal-title":"Bioessays."},{"key":"10.1016\/j.ymthe.2025.12.034_bib63","doi-asserted-by":"crossref","first-page":"5539544","DOI":"10.1155\/2021\/5539544","article-title":"Efforts made to eliminate drug-resistant malaria and its challenges","volume":"2021","author":"Amelo","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2025.12.034_bib64","first-page":"215","article-title":"Antimalarial drugs resistance genes of Plasmodium falciparum: a review","volume":"68","author":"Tchekounou","year":"2022","journal-title":"Ann. Parasitol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib65","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.2147\/IDR.S279433","article-title":"Antimalarial drug resistance and novel targets for antimalarial drug discovery","volume":"13","author":"Shibeshi","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ymthe.2025.12.034_bib66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s40471-021-00266-5","article-title":"Antimalarial drug resistance and implications for the WHO global technical strategy","volume":"8","author":"Ippolito","year":"2021","journal-title":"Curr. Epidemiol. Rep."},{"key":"10.1016\/j.ymthe.2025.12.034_bib67","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","article-title":"Molecular mechanisms of drug resistance in Plasmodium falciparum malaria","volume":"74","author":"Wicht","year":"2020","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib68","series-title":"Plasmodium Species and Drug Resistance","article-title":"P. falciparum and its molecular markers of resistance to antimalarial drugs","author":"Hodoameda","year":"2021"},{"key":"10.1016\/j.ymthe.2025.12.034_bib69","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/1566524020666200207123253","article-title":"An overview of available antimalarials: discovery, mode of action and drug resistance","volume":"20","author":"Tang","year":"2020","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.034_bib70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/emph\/eoaa016","article-title":"Effect of drug dose and timing of treatment on the emergence of drug resistance in vivo in a malaria model","volume":"2020","author":"Acosta","year":"2020","journal-title":"Evol. Med. Public Health"},{"key":"10.1016\/j.ymthe.2025.12.034_bib71","series-title":"Intra-Host Dynamics of Malaria Parasites: A Multifaceted Examination of Ecology, Evolution, Drug Resistance, and Competition","author":"Segovia","year":"2024"},{"key":"10.1016\/j.ymthe.2025.12.034_bib72","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41576-021-00349-5","article-title":"Advances and Opportunities in Malaria Population Genomics","volume":"22","author":"Neafsey","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2025.12.034_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.31254\/jahm.2022.8209","article-title":"Drug resistance in Plasmodium, future malaria management strategies and importance of medicinal plants","volume":"8","author":"Cheema","year":"2022","journal-title":"J. Ayu. Her. Med."},{"key":"10.1016\/j.ymthe.2025.12.034_bib74","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/0115672018291253240115012327","article-title":"Current trends in nanotechnology-based drug delivery systems for the diagnosis and treatment of malaria: A review","volume":"22","author":"Deshmukh","year":"2025","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ymthe.2025.12.034_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.105828","article-title":"Current methods for the detection of antimalarial drug resistance in Plasmodium parasites infecting humans","volume":"216","author":"Slater","year":"2021","journal-title":"Acta Trop."},{"key":"10.1016\/j.ymthe.2025.12.034_bib76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpddr.2020.11.006","article-title":"Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions \u2013 India and sub-Saharan Africa","volume":"15","author":"Arya","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ymthe.2025.12.034_bib77","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4269\/ajtmh.2012.12-0025","article-title":"Artemisinin-resistant malaria: research challenges, opportunities, and public health implications","volume":"87","author":"Fairhurst","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ymthe.2025.12.034_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111292","article-title":"Genome editing as control tool for filarial infections","volume":"137","author":"Kwarteng","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2025.12.034_bib79","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66277","article-title":"Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness","volume":"10","author":"Stokes","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.12.034_bib80","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial Drug Discovery: Progress and Approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.12.034_bib81","series-title":"Advanced Pharmacological Uses of Medicinal Plants and Natural Products","first-page":"154","article-title":"Anti-malarial drug resistance: need for novel natural Products","author":"Dwivedi","year":"2020"},{"key":"10.1016\/j.ymthe.2025.12.034_bib82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(24)02706-5","article-title":"Regional action is needed to halt antimalarial drug resistance in Africa","volume":"405","author":"Martinez-Vega","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.12.034_bib83","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41579-024-01099-x","article-title":"Towards next-generation treatment options to combat Plasmodium falciparum malaria","volume":"23","author":"Okombo","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3492696","article-title":"Assessing the roles of molecular markers of antimalarial drug resistance and the host pharmacogenetics in drug-resistant malaria","volume":"2022","author":"Hodoameda","year":"2022","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.ymthe.2025.12.034_bib85","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1042\/BST20210281","article-title":"CRISPR\/Cas9 and genetic screens in malaria parasites: small genomes, big impact","volume":"50","author":"Ishizaki","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ymthe.2025.12.034_bib86","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/0113892010316710240626042205","article-title":"Applications of CRISPR in parasitology","volume":"26","author":"Tee","year":"2025","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib87","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1073\/pnas.1812317115","article-title":"Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility","volume":"115","author":"Demas","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.034_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1366563","article-title":"Detection of novel Plasmodium falciparum coronin gene mutations in a recrudescent ACT-treated patient in South-Western Nigeria","volume":"14","author":"Ajibaye","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib89","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.parint.2018.06.002","article-title":"CRISPR\/Cas9 system in Plasmodium falciparum using the centromere plasmid","volume":"67","author":"Payungwoung","year":"2018","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ymthe.2025.12.034_bib90","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02640-19","article-title":"Plasmodium falciparum resistance to a lead benzoxaborole due to blocked compound activation and altered ubiquitination or sumoylation","volume":"11","author":"Sindhe","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2025.12.034_bib91","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.chembiol.2020.04.001","article-title":"Inhibition of resistance-refractory P. falciparum kinase PKG delivers prophylactic, blood stage, and transmission-blocking antiplasmodial activity","volume":"27","author":"Vanaerschot","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib92","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nbt.2925","article-title":"Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system","volume":"32","author":"Ghorbal","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fpara.2023.1076759","article-title":"Identification of an in vitro artemisinin-resistant Plasmodium falciparum kelch13 R515K mutant parasite in Senegal","volume":"2","author":"Sene","year":"2023","journal-title":"Front. Parasitol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib94","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/ph14111171","article-title":"CRISPR-Cas technology: emerging applications in clinical microbiology and infectious diseases","volume":"14","author":"Serajian","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymthe.2025.12.034_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.anifeedsci.2023.115716","article-title":"Influence of Agroecological Practices on Rumen Microbiota Associated with Methane Emission in Dairy Cattle","volume":"303","author":"Roques","year":"2023","journal-title":"Anim. Feed Sci. Technol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib96","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13071-022-05211-z","article-title":"Transgenesis in parasitic helminths: a brief history and prospects for the future","volume":"15","author":"Quinzo","year":"2022","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ymthe.2025.12.034_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902312","article-title":"CRISPR\/Cas systems in genome editing: methodologies and tools for sgRNA design, off-target evaluation, and strategies to mitigate off-target effects","volume":"7","author":"Manghwar","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.12.034_bib98","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/genes11080942","article-title":"Advances in genomics for drug development","volume":"11","author":"Spreafico","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.ymthe.2025.12.034_bib99","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03239-21","article-title":"A phosphoinositide-binding protein acts in the trafficking pathway of hemoglobin in the malaria parasite Plasmodium falciparum","volume":"13","author":"Mukherjee","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2025.12.034_bib100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3906\/biy-1912-52","article-title":"Bioethical issues in genome editing by CRISPR-Cas9 technology","volume":"44","author":"Ayano\u011flu","year":"2020","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib101","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cj.2024.09.003","article-title":"Enhancing resistance to bacterial blight in rice using CRISPR-based base editing technology","volume":"13","author":"Li","year":"2025","journal-title":"Crop J."},{"key":"10.1016\/j.ymthe.2025.12.034_bib102","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41587-023-02095-x","article-title":"Prime editing using CRISPR-Cas12a and circular RNAs in human cells","volume":"42","author":"Liang","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.12.034_bib103","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tibtech.2023.03.004","article-title":"Prime editing: advances and therapeutic applications","volume":"41","author":"Zhao","year":"2023","journal-title":"Trends Biotechnol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:35:45Z","timestamp":1775057745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625010573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1525001625010573"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.034","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative approach in malaria research: Harnessing CRISPR-Cas9 for antimalarial drug-resistance studies in Africa","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}